<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03149913</url>
  </required_header>
  <id_info>
    <org_study_id>BTK 1</org_study_id>
    <nct_id>NCT03149913</nct_id>
  </id_info>
  <brief_title>Local Paclitaxel or Balloon Angioplasty Below the Knee</brief_title>
  <acronym>SAMBA</acronym>
  <official_title>Does Local Paclitaxel Improve the Efficacy of Balloon Angioplasty Without Stent Implantation for Treatment of Below the Knee Artery Lesions?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prof. Dr. med. Gunnar Tepe</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>InnoRa GmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Klinikum Rosenheim</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with claudication or critical limb ischemia will be treated either with uncoated
      balloons or paclitaxel coated balloons in order to enhance the vessel patency in stenosed or
      occluded below the knee arteries
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After successful guide wire passage of the below the knee index lesions the patients will
      either receive a treatment with a conventional uncoated balloon or a balloon coated with
      paclitaxel. Only patients who require follow-up angiography after 6 months will be included
      in this study. The primary endpoint (index vessel occluded or still open) is at 6 months -
      the patients will be also followed for 24 months for clinical endpoints. In addition an MRI
      is planned at 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 15, 2016</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The vessel patency (measured by angiography at 6 months) will be compared after patients have been treated either with paclitaxel coated or uncoated balloons (control) in BTK arteries</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>drug coated balloon versus uncoated balloon</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Occlusion rate of the target lesion at 6 months</measure>
    <time_frame>6 +/- 1 months</time_frame>
    <description>by digital substraction angiogram or MRI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>target lesion revascularization</measure>
    <time_frame>3, 6, 12 and 24 months</time_frame>
    <description>repeat intervention</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Walking distance</measure>
    <time_frame>3, 6, 12 and 24 months</time_frame>
    <description>Evaluation of Rutherford category</description>
  </other_outcome>
  <other_outcome>
    <measure>Wound status</measure>
    <time_frame>3, 6, 12 and 24 months</time_frame>
    <description>improvement, no change, worsening</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Stenosis</condition>
  <condition>Occlusion</condition>
  <condition>Restenosis</condition>
  <arm_group>
    <arm_group_label>Drug coated balloon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SeQuentPlease OTW paclitaxel coated balloon catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>uncoated PTA balloon catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard of care uncoated BTK balloon catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SequentPlease OTW paclitaxel coated balloon catheter</intervention_name>
    <description>PTA with SequentPlease OTW paclitaxel coated balloon catheter</description>
    <arm_group_label>Drug coated balloon</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>conventional uncoated balloon for BTK endovascular therapy</intervention_name>
    <description>PTA with uncoated balloon for BTK endovascular therapy</description>
    <arm_group_label>uncoated PTA balloon catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18 years of age

          -  Chronic stenotic or occlusive atherosclerotic disease of the infrapopliteal arteries

          -  Rutherford 2-5 patients

          -  Patients with ≤ 2 BTK lesions (≥ 70% diameter stenosis)

          -  Lesion length limited to 5-25 cm

        Exclusion Criteria:

          -  Planned or foreseeable amputation

          -  Previous amputation at the index limb

          -  Index vessel with no run-off to the foot distal to the index lesion

          -  Prior treatment of the index lesion with a drug coated balloon

          -  In-stent restenosis

          -  Life expectancy &lt;1 year

          -  Known creatinine &gt;1.4 mg% if patient is not on dialysis

          -  Acute thrombus in the index limb

          -  Aneurysm in the index leg

          -  Known hypersensitivity or contraindication to aspirin, heparin, clopidogrel,
             abciximab, paclitaxel

          -  Patients with concomitant medical illnesses that require cytostatic or radiation
             therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gunnar Tepe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>RoMed Klinikum Rosenheim</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gunnar Tepe, MD</last_name>
    <phone>+498031365</phone>
    <phone_ext>3551</phone_ext>
    <email>gunnar.tepe@ro-med.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>LKH-Univ. Klinikum Graz</name>
      <address>
        <city>Graz</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>M. Brodmann, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Bad Krozingen</name>
      <address>
        <city>Bad Krozingen</city>
        <state>BW</state>
        <zip>73000</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Zeller, MD</last_name>
      <phone>076334022431</phone>
      <email>thomas.zeller@herzzentrum.de</email>
    </contact>
    <investigator>
      <last_name>Thomas Zeller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tepe</name>
      <address>
        <city>Rosenheim</city>
        <state>BW</state>
        <zip>83022</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gunnar Tepe, MD</last_name>
      <phone>80313653551</phone>
      <email>gunnar.tepe@ro-med.de</email>
    </contact>
    <investigator>
      <last_name>Gunnar Tepe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Arnsberg</name>
      <address>
        <city>Arnsberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>M. Lichtenberg, MD</last_name>
    </contact>
    <investigator>
      <last_name>M Lichtenberg</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ev.-Luth. Diakonissenanstalt zu Flensburg</name>
      <address>
        <city>Flensburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>S. Mueller-Huelsbeck, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Mülheim a. d. Ruhr</name>
      <address>
        <city>Mülheim</city>
        <zip>45468</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>C. Nolte-Ernsting, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Würzburg</name>
      <address>
        <city>Würzburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>R. Kickuth, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2017</study_first_submitted>
  <study_first_submitted_qc>May 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2017</study_first_posted>
  <last_update_submitted>May 10, 2017</last_update_submitted>
  <last_update_submitted_qc>May 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Klinikum Rosenheim</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. Gunnar Tepe</investigator_full_name>
    <investigator_title>Director of the Deparment of Radiology, Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>below the knee artery</keyword>
  <keyword>endovascular</keyword>
  <keyword>drug coated balloon</keyword>
  <keyword>critical limb ischemia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
    <mesh_term>Albumin-Bound Paclitaxel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

